Cargando…
Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
BACKGROUND: Research on risk factors for neuropsychiatric adverse events (NAEs) in smoking cessation with pharmacotherapy is scarce. We aimed to identify predictors and develop a prediction model for risk of NAEs in smoking cessation with medications using Bayesian regularization. METHODS: Bayesian...
Autores principales: | Truong, Van Thi Thanh, Green, Charles, Pedroza, Claudia, Hwang, Lu-Yu, Rajan, Suja S., Suchting, Robert, Cinciripini, Paul, Tyndale, Rachel F., Lerman, Caryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148544/ https://www.ncbi.nlm.nih.gov/pubmed/37118656 http://dx.doi.org/10.1186/s12874-023-01931-7 |
Ejemplares similares
-
Pharmacotherapy of smoking cessation
por: Jiloha, R. C.
Publicado: (2014) -
Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking
por: Tyndale, Rachel F., et al.
Publicado: (2015) -
Optimal use of smoking cessation pharmacotherapy
por: Mendelsohn, Colin
Publicado: (2022) -
Gender Stratified Gene and Gene–Treatment Interactions in Smoking Cessation
por: Lee, Wonho, et al.
Publicado: (2011) -
Review of pharmacotherapy for smoking cessation in patients with schizophrenia
por: Shawen, Avery E., et al.
Publicado: (2018)